Bleakley Financial Group LLC Buys 134 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Bleakley Financial Group LLC increased its stake in Dolby Laboratories, Inc. (NYSE:DLB) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,444 shares of the electronics maker’s stock after purchasing an additional 134 shares during the period. Bleakley Financial Group LLC’s holdings in Dolby Laboratories were worth $814,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Quarry LP boosted its stake in Dolby Laboratories by 248.2% in the second quarter. Quarry LP now owns 296 shares of the electronics maker’s stock worth $25,000 after buying an additional 211 shares in the last quarter. VisionPoint Advisory Group LLC boosted its stake in Dolby Laboratories by 86.9% in the third quarter. VisionPoint Advisory Group LLC now owns 370 shares of the electronics maker’s stock worth $29,000 after buying an additional 172 shares in the last quarter. Blue Trust Inc. boosted its stake in Dolby Laboratories by 75.7% in the fourth quarter. Blue Trust Inc. now owns 369 shares of the electronics maker’s stock worth $29,000 after buying an additional 159 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Dolby Laboratories by 52.7% in the first quarter. Tower Research Capital LLC TRC now owns 400 shares of the electronics maker’s stock worth $34,000 after buying an additional 138 shares in the last quarter. Finally, Fifth Third Bancorp boosted its stake in Dolby Laboratories by 175.3% in the third quarter. Fifth Third Bancorp now owns 446 shares of the electronics maker’s stock worth $35,000 after buying an additional 284 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Stock Down 1.6 %

Shares of DLB stock opened at $80.25 on Friday. The stock has a fifty day moving average of $81.71 and a 200 day moving average of $83.35. Dolby Laboratories, Inc. has a 52 week low of $75.87 and a 52 week high of $91.01. The firm has a market capitalization of $7.67 billion, a price-to-earnings ratio of 41.58 and a beta of 0.97.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, February 1st. The electronics maker reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.14. Dolby Laboratories had a return on equity of 10.21% and a net margin of 14.70%. The company had revenue of $315.57 million during the quarter, compared to analyst estimates of $310.98 million. Equities research analysts anticipate that Dolby Laboratories, Inc. will post 2.63 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 22nd. Investors of record on Tuesday, February 13th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend was Monday, February 12th. Dolby Laboratories’s payout ratio is 62.18%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on DLB shares. Rosenblatt Securities reissued a “buy” rating and set a $98.00 price objective on shares of Dolby Laboratories in a research note on Wednesday, January 31st. StockNews.com raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd.

Insider Buying and Selling

In related news, SVP John D. Couling sold 33,560 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $80.81, for a total value of $2,711,983.60. Following the completion of the sale, the senior vice president now owns 108,519 shares of the company’s stock, valued at $8,769,420.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 9,030 shares of the stock in a transaction on Wednesday, January 17th. The stock was sold at an average price of $83.51, for a total value of $754,095.30. Following the completion of the transaction, the chief executive officer now owns 83,721 shares in the company, valued at $6,991,540.71. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP John D. Couling sold 33,560 shares of the stock in a transaction on Friday, February 9th. The stock was sold at an average price of $80.81, for a total value of $2,711,983.60. Following the completion of the transaction, the senior vice president now owns 108,519 shares of the company’s stock, valued at approximately $8,769,420.39. The disclosure for this sale can be found here. 39.54% of the stock is currently owned by insiders.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.